Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:55:48 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ONTX - ONCONOVA THERAPEUTICS INC - http://www.onconova.com.
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONTX - QDEFUNCT0.9953    1.45  0.5509Apr 02Apr 0215 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-02 07:15U:ONTXNews ReleaseTraws Pharma Announces New Employee Inducement Grants
2024-04-02 07:00U:ONTXNews ReleaseOnconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
2024-03-08 08:00U:ONTXNews ReleaseOnconova Therapeutics' Rigosertib Poster Selected for AACR 2024
2023-12-12 08:00U:ONTXNews ReleaseOnconova Therapeutics ¢ € ™ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
2023-12-08 16:05U:ONTXNews ReleaseOnconova Therapeutics ¢ € ™ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i ¢ € ™s
2023-11-28 08:00U:ONTXNews ReleaseOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets ¢ € ™ Nineteenth Annual Emerging Growth Equity Conference
2023-11-14 16:05U:ONTXNews ReleaseOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
2023-11-07 16:05U:ONTXNews ReleaseOnconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
2023-11-02 10:37U:ONTXNews ReleaseOnconova Therapeutics ¢ € ™ ASH Poster To Focus on Narazaciclib in MCL
2023-10-24 08:00U:ONTXNews ReleaseOnconova Expands Leadership Team with Two Key Appointments
2023-10-19 08:00U:ONTXNews ReleasePromising Preclinical Narazaciclib Data Presented at MCL Meeting
2023-10-12 08:00U:ONTXNews ReleaseEncouraging Rigosertib Data Presented at EADV as Late Breaker
2023-09-28 08:00U:ONTXNews ReleaseOnconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
2023-09-06 08:00U:ONTXNews ReleaseOnconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-10 16:05U:ONTXNews ReleaseOnconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
2023-08-03 16:05U:ONTXNews ReleaseOnconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023
2023-06-14 08:00U:ONTXNews ReleaseOnconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma
2023-06-05 08:01U:ONTXNews ReleaseOnconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting
2023-05-25 08:00U:ONTXNews ReleaseOnconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade
2023-05-15 16:18U:ONTXNews ReleaseOnconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update